Treatment outcome | Analysis | Age category (years) | |||
---|---|---|---|---|---|
Total |  < 1 | 1–4 |  ≥ 5 | ||
N | ITT | 308 | 13 | 176 | 119 |
PP | 294 | 11 | 168 | 115 | |
Early treatment failure (ETF), n (%) | ITT | 0 | 0 | 0 | 0 |
PP | 0 | 0 | 0 | 0 | |
Late clinical failure (LCF), n (%) | ITT | 5 (1.6) | 0 | 3 (1.7) | 2 (1.7) |
PP | 5 (1.7) | 0 | 3 (1.8) | 2 (1.7) | |
Late parasitological failure (LPF), n (%) | ITT | 12 (3.9) | 0 | 6 (3.5) | 6 (5.0) |
PP | 9 (3.1) | 0 | 6 (3.6) | 3 (2.6) | |
D28 PCR-uncorrected ACPR, (%) | ITT | 94.5 | 100 | 94.9 | 93.3 |
PP | 95.2 | 100 | 94.6 | 95.7 | |
Parasite recurrence, n | ITT | 17 | 0 | 9 | 8 |
PP | 14 | 0 | 9 | 5 | |
P. falciparum recrudescence on PCR, n | ITT | 6 | 0 | 4 | 2 |
PP | 6 | 0 | 4 | 2 | |
P. falciparum reinfection on PCR, n | ITT | 8 | 0 | 5 | 3 |
PP | 8 | 0 | 5 | 3 | |
aIndeterminate or missing PCR, n | ITT | 3 | 0 | 0 | 3 |
PP | 0 | 0 | 0 | 0 | |
Day 28 PCR-corrected ACPR, (%) | ITT | 98.0 | 100 | 97.7 | 98.3 |
PP | 98.0 | 100 | 97.6 | 98.3 |